Literature DB >> 1399206

Recessive dystrophic epidermolysis bullosa treated with phenytoin.

A A Abahussein1, A A al-Zayir, W Z Mostafa, A N Okoro.   

Abstract

Three patients with severe recessive dystrophic epidermolysis bullosa were treated with oral phenytoin and palliative and supportive measures for variable periods. Their progress was compared with that of three milder cases managed only with palliative and supportive measures. The phenytoin-treated group showed marked decrease in blister count, increase in trauma tolerance, a rise in hemoglobin level, and considerable weight gain. The results support earlier reports that collagenase inhibitors are useful in controlling blister formation in recessive dystrophic epidermolysis bullosa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1399206     DOI: 10.1111/j.1365-4362.1992.tb01385.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  2 in total

1.  A case of non-hallopeau-siemens recessive dystrophic epidermolysis bullosa.

Authors:  Gyo Shin Kang; Woo Tae Ko; Jae Hong Kim; Sung Min Choi; Ae Suk Kim; Dong Hoon Kim; Moo Kyu Suh
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

2.  Oral viscous budesonide as a first-line approach to esophageal stenosis in epidermolysis bullosa: an open-label trial in six children.

Authors:  Andrea Zanini; Sophie Guez; Simona Salera; Giorgio Farris; Anna Morandi; Valerio Gentilino; Ernesto Leva; Francesca Manzoni; Maria Angela Pavesi; Susanna Esposito; Francesco Macchini
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.